Williams Cancer Foundation
2 clinical trials · Sponsor
◉ Watch Williams Cancer Foundation
| Record | Firm | Date |
|---|---|---|
| Phase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate Cancer (NCT05544227) | Williams Cancer Foundation | 2023-02-01 |
| Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors (NCT05544240) | Williams Cancer Foundation | 2023-02-01 |
Track Williams Cancer Foundation automatically
Every clearance here is in the API, with alerts when new ones post.